View Article

Abstract

From the world of herbs the present therapies are being originated which are acting as the best alternate for the conventional therapies. In the view of the same numerous researchers are working to highlight the present herbs of various regions. The present work tries to emphasize on the pharmacognostic, pharmachemistrical and pharmaco-economical aspects of anti obesity herbs. The obesity is considered to be the originator of many other diseases like diabetes, hypertension, asthma, osteoarthritis and cancer etc. This might have diverted the physicians and researchers to find an alternate along with the ongoing therapies. However, these alternates must be economical and easily assessable.

Keywords

Herbs, Economical, Pharmacognostic, Anti-Obesity, Therapies.

Introduction

Obesity is a global epidemic that has shown a steady increase in morbimortality indicators; it is considered a social problem and entails serious health risks 1-7. One of the alternatives in the treatment of obesity is the traditional use of medicinal plants, which supports the research and development of obesity phytotherapy 8-11. Pharmacological strategies are recommended for the treatment of obesity, mainly because they are non-invasive. Recommended pharmaceuticals include sibutramine, fluoxetine, sertraline, orlistat and topiramate 12-13. These medicines should be used with caution, especially in patients with cardiovascular disorders, because they possible may aggravate the clinical picture. Among the available therapies plant-based medications may contribute to satiety, increased metabolism and accelerated weight loss 14. The present work, focus on some of the herbal plants which are proven to be efficacious in the treatment of obesity.

  1. Tripterygium wilfordii

       
            fig-1.png
       

The active chemical constituent in the plant is celastrol which suppresses food intake, blocks reduction of energy expenditure and leads up to 45% weight loss in hyperleptinemic diet-induced obesity in mice by increasing sensitivity of leptin 15.

2. Panax ginseng

       
            fig-2.png
       

Numerous researches have reported that ginsenosides including Rg3, Rg2 can effectively inhibit the adipogenesis in 3T3-L1 preadipocytes. In addition, they can also decrease lipid accumulation, adipocyte size and adipose weight, and prevent triglyceride deposition. The molecular regulation of ginsenosides on adipogenesis may be related with the down-regulation of the protein expression of adipogenesis-related transcription factors and the key lipogenic enzymes in 3T3-L1 cells. It was observed that ginsenosides play an anti-adipogenic role mainly by activating the adenosine monophosphate-activated protein kinase (AMPK) pathway and down-regulating PPAR ? related pathways 16.

3. Ilex paraguariensis

Indole-3-carbinol (I3C) has shown to exhibit anti-obesity activity by reducing body weight and fat in animals fed a high-fat diet and by inhibiting the differentiation of 3T3-L1 preadipocytes . Being an activator of the aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor crucial in adipogenesis and angiogenesis, we considered that I3C executes its activities through the AhR. Although I3C has been shown to inhibit the differentiation of preadipocytes, knowledge regarding its effects on lipid accumulation in matures adipocytes and on adipocyte-associated angiogenesis is limited. Because increased triglyceride (TG) accumulation in mature adipocytes is positively associated with obesity and associated metabolic disorders, compounds that reduce the TG content in adipocytes may have therapeutic roles in obesity and related pathological disorders 17.

       
            fig-3.png
       

4. Hibiscus sabdariffa:

HSE (or tea) inhibited the activity of ?-amylase, blocking sugars and starch absorption, which may assist in weight loss. The ability of HSE to reduce body weight was attributed to H. sabdariffa polyphenols and flavonoids, through the inhibition of fat accumulation. Moreover, it also inhibits lipid accumulation and suppression of adipogenesis through the PPAR? pathway 18.

       
            fig-4.png
       

5. Coffee:

       
            fig-5.png
       

Caffeine, and other polyphenolic compounds in green coffee bean extract (GCBE) act to suppress body weight gain and visceral fat accumulation. The CGA is possibly effective against weight gain and fat accumulation by inhibition of fat absorption and activation of fat metabolism in the liver. Oral administration of CGA in dose of 30 and 60?mg/kg/day for 2 weeks dramatically reduced the level of hepatic triglycerides. The suppressive effect of CGA on hepatic triglycerides accumulation was more potent than that of GCBE. Chlorogenic acid significantly inhibited fatty acid synthase, 3-hydroxy-3-methylglutaryl CoA reductase, and acyl-CoA cholesterol acyltransferase activities, while they increased fatty acid beta-oxidation activity and peroxisome proliferator-activated receptors alpha expression in the liver compared to the high-fat group and results suggested that CGA can improve body weight, lipid metabolism, and obesity-related hormones level 19.

6. Caralluma fimbriata:

The exact mechanism of action of this effect is not well established. Pregnane glycosides present in CFE may act via multiple mechanisms.  The  decline  in  food  intake  may  reflect direct  intervention  in  appetite  control  at  the  level  of  the hypothalamus, where the pregnane glycosides are known to act. There  is also  evidence  that they  act  directly on  adipose tissue,  by inhibiting  adipocyte  proliferation  and  differentiation. Carallumafimbriata  contains  pregnane  glycosides  which  are believed  to  block  the  activity  of  citrate  lyase.  By blocking this enzyme, Carallumafimbriata may block the formation of fat by the body.  Further, Carallumafimbriata also blocks another enzyme called Malonyl Coenzyme A.  By blocking this enzyme, fat formation is further blocked and the body is forced to burn its fat reserves. This might accelerate the rate of fat loss by the body. An alternative hypothesis  is  that  CFE  may  down regulate  ghrelin synthesis  in the stomach  and  subsequently  neuropeptide-Y  in  the  hypothalamus, with ultimately the same effect of appetite suppression 20.

       
            fig-6.png
       

Economical aspects of Anti-obesity Drugs:

The economical aspects of the anti obesity drugs are very important as these medicines are to be taken by the patients for the long duration of time. According to a current medical research the anti obesity treatment may takes from several months to year or so. Moreover, severity of condition also directly affects the time period of treatment. The additional problem arises when the maintaince of the same is to be carried out to prevent the reoccurrence of this problem. Hence a lot of finance is being engaged while treating and managing the obesity. It has also been reported that herbal anti-obesity products are highly prevalent in the commercial market than the allopathic formulations 21-22.   

CONCLUSION:

Nowadays a lot of research is going on globally involving the use of herbs. Most of the diseases in the present scenario is being treated and managed with the use of herbal medicines. Keeping all this into consideration it becomes necessary for the researchers all over the world to clarify the chemistry of the herbal based products. This will also helps in overcoming the adverse drug reactions. At the same time the economical aspects of the herbal formulation are too very important. The market scenario will suggest that the formulations with good quality along with affordable price will have better chances of survival in the market.

REFERENCES

  1. Fruh SM. Obesity: Risk factors, complications, and strategies for sustainable long-term weight management. J Am Assoc Nurse Pract. 2017; 29(S1): S3-S14.
  2. Lin X, Li H. Obesity: Epidemiology, Pathophysiology, and Therapeutics. Front Endocrinol (Lausanne). 2021; 12: 706978.
  3. Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care. 2016; 22(7 Suppl): s176-185.
  4. Elmaleh-Sachs A, Schwartz JL, Bramante CT, Nicklas JM, Gudzune KA, Jay M. Obesity Management in Adults: A Review. JAMA. 2023; 330(20): 2000-2015.
  5. Prashar D, Singh P. Obesity Medications: Pharmaco-Economical Outline. Asian J. Res. Pharm. Sci. 2020; 10(3):195-198.
  6. Prashar D, Sahu RK. A Methodological Analysis on Obesity. Int J Life Sci Scienti Res 2015; 1(1): 12-14.
  7. Sahu RK, Prashar D. Current Treatment Strategies for Obesity Including Indian scenario. Asian Journal of Pharmaceutics, 2016; 10(03): S343-S349.
  8. Gasmi A, Noor S, Mujawdiya PK, Akram M, Manzoor A, Bjørklund G. Herbal Treatments for Obesity: A Review. Curr Med Chem. 2024 Mar 20. doi: 10.2174/0109298673287491240315055726. Epub ahead of print.
  9. Hasani-Ranjbar S, Nayebi N, Larijani B, Abdollahi M. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J Gastroenterol. 2009; 15(25): 3073-3085.
  10. Maunder A, Bessell E, Lauche R, Adams J, Sainsbury A, Fuller NR. Effectiveness of herbal medicines for weight loss: A systematic review and meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2020; 22(6): 891-903.
  11. Liu Y, Sun M, Yao H, Liu Y, Gao R. Herbal Medicine for the Treatment of Obesity: An Overview of Scientific Evidence from 2007 to 2017. Evid Based Complement Alternat Med. 2017; 2017: 8943059.
  12. Gudzune KA, Kushner RF. Medications for Obesity: A Review. JAMA. 2024; 332(7): 571-584.
  13. Chakhtoura M, Haber R, Ghezzawi M, Rhayem C, Tcheroyan R, Mantzoros CS. Pharmacotherapy of obesity: an update on the available medications and drugs under investigation. EClinicalMedicine. 2023; 58: 101882.
  14. Singh P. Herbal approach for obesity management. New Insights Obes Gene Beyond 2018; 2: 5-16.
  15. Liu J, Lee J, Salazar Hernandez MA, Mazitschek R, Ozcan U. Treatment of obesity with celastrol. Cell. 2015; 161(5): 999-1011.
  16. Shin SS, Yoon M. Korean red ginseng (Panax ginseng) inhibits obesity and improves lipid metabolism in high fat diet-fed castrated mice. J Ethnopharmacol. 2018; 210: 80-87.
  17. Choi Y, Kim Y, Park S, Lee KW, Park T. Indole-3-carbinol prevents diet-induced obesity through modulation of multiple genes related to adipogenesis, thermogenesis or inflammation in the visceral adipose tissue of mice. J Nutr Biochem. 2012; 23(12): 1732-1739.
  18. Chang HC, Peng CH, Yeh DM, Kao ES, Wang CJ. Hibiscus sabdariffa extract inhibits obesity and fat accumulation, and improves liver steatosis in humans. Food Funct. 2014; 5(4): 734-739.
  19. Santos RM, Lima DR. Coffee consumption, obesity and type 2 diabetes: a mini-review. Eur J Nutr. 2016; 55(4): 1345-1358.
  20. Jayawardena R, Francis TV, Abhayaratna S, Ranasinghe P. The use of Caralluma fimbriata as an appetite suppressant and weight loss supplement: a systematic review and meta-analysis of clinical trials. BMC Complement Med Ther. 2021; 21(1): 279.
  21. Nagi MA, Ahmed H, Rezq MAA, Sangroongruangsri S, Chaikledkaew U, Almalki Z, Thavorncharoensap M. Economic costs of obesity: a systematic review. Int J Obes (Lond). 2024; 48(1): 33-43.
  22. Okunogbe A, Nugent R, Spencer G, Powis J, Ralston J, Wilding J. Economic impacts of overweight and obesity: current and future estimates for 161 countries. BMJ Glob Health. 2022; 7(9): e009773.

Reference

  1. Fruh SM. Obesity: Risk factors, complications, and strategies for sustainable long-term weight management. J Am Assoc Nurse Pract. 2017; 29(S1): S3-S14.
  2. Lin X, Li H. Obesity: Epidemiology, Pathophysiology, and Therapeutics. Front Endocrinol (Lausanne). 2021; 12: 706978.
  3. Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care. 2016; 22(7 Suppl): s176-185.
  4. Elmaleh-Sachs A, Schwartz JL, Bramante CT, Nicklas JM, Gudzune KA, Jay M. Obesity Management in Adults: A Review. JAMA. 2023; 330(20): 2000-2015.
  5. Prashar D, Singh P. Obesity Medications: Pharmaco-Economical Outline. Asian J. Res. Pharm. Sci. 2020; 10(3):195-198.
  6. Prashar D, Sahu RK. A Methodological Analysis on Obesity. Int J Life Sci Scienti Res 2015; 1(1): 12-14.
  7. Sahu RK, Prashar D. Current Treatment Strategies for Obesity Including Indian scenario. Asian Journal of Pharmaceutics, 2016; 10(03): S343-S349.
  8. Gasmi A, Noor S, Mujawdiya PK, Akram M, Manzoor A, Bjørklund G. Herbal Treatments for Obesity: A Review. Curr Med Chem. 2024 Mar 20. doi: 10.2174/0109298673287491240315055726. Epub ahead of print.
  9. Hasani-Ranjbar S, Nayebi N, Larijani B, Abdollahi M. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J Gastroenterol. 2009; 15(25): 3073-3085.
  10. Maunder A, Bessell E, Lauche R, Adams J, Sainsbury A, Fuller NR. Effectiveness of herbal medicines for weight loss: A systematic review and meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2020; 22(6): 891-903.
  11. Liu Y, Sun M, Yao H, Liu Y, Gao R. Herbal Medicine for the Treatment of Obesity: An Overview of Scientific Evidence from 2007 to 2017. Evid Based Complement Alternat Med. 2017; 2017: 8943059.
  12. Gudzune KA, Kushner RF. Medications for Obesity: A Review. JAMA. 2024; 332(7): 571-584.
  13. Chakhtoura M, Haber R, Ghezzawi M, Rhayem C, Tcheroyan R, Mantzoros CS. Pharmacotherapy of obesity: an update on the available medications and drugs under investigation. EClinicalMedicine. 2023; 58: 101882.
  14. Singh P. Herbal approach for obesity management. New Insights Obes Gene Beyond 2018; 2: 5-16.
  15. Liu J, Lee J, Salazar Hernandez MA, Mazitschek R, Ozcan U. Treatment of obesity with celastrol. Cell. 2015; 161(5): 999-1011.
  16. Shin SS, Yoon M. Korean red ginseng (Panax ginseng) inhibits obesity and improves lipid metabolism in high fat diet-fed castrated mice. J Ethnopharmacol. 2018; 210: 80-87.
  17. Choi Y, Kim Y, Park S, Lee KW, Park T. Indole-3-carbinol prevents diet-induced obesity through modulation of multiple genes related to adipogenesis, thermogenesis or inflammation in the visceral adipose tissue of mice. J Nutr Biochem. 2012; 23(12): 1732-1739.
  18. Chang HC, Peng CH, Yeh DM, Kao ES, Wang CJ. Hibiscus sabdariffa extract inhibits obesity and fat accumulation, and improves liver steatosis in humans. Food Funct. 2014; 5(4): 734-739.
  19. Santos RM, Lima DR. Coffee consumption, obesity and type 2 diabetes: a mini-review. Eur J Nutr. 2016; 55(4): 1345-1358.
  20. Jayawardena R, Francis TV, Abhayaratna S, Ranasinghe P. The use of Caralluma fimbriata as an appetite suppressant and weight loss supplement: a systematic review and meta-analysis of clinical trials. BMC Complement Med Ther. 2021; 21(1): 279.
  21. Nagi MA, Ahmed H, Rezq MAA, Sangroongruangsri S, Chaikledkaew U, Almalki Z, Thavorncharoensap M. Economic costs of obesity: a systematic review. Int J Obes (Lond). 2024; 48(1): 33-43.
  22. Okunogbe A, Nugent R, Spencer G, Powis J, Ralston J, Wilding J. Economic impacts of overweight and obesity: current and future estimates for 161 countries. BMJ Glob Health. 2022; 7(9): e009773.

Photo
Vivek Kumar
Corresponding author

Department of Pharmacy, LR Institute of Pharmacy, Jabli-Kyar Solan HP-India

Photo
Deepak Prashar
Co-author

Department of Pharmacy, LR Institute of Pharmacy, Jabli-Kyar Solan HP-India

Photo
Sahil Kumar
Co-author

Department of Pharmacy, Shanti Niketan College of Pharmacy, Ratti HP-India

Photo
Jatin
Co-author

Department of Pharmacy, Shanti Niketan College of Pharmacy, Ratti HP-India

Photo
Lokender Singh
Co-author

Department of Pharmacy, Shanti Niketan College of Pharmacy, Ratti HP-India

Deepak Prashar, Sahil Kumar, Jatin, Lokender Singh, Vivek Kumar*, Pharmacognostic, Pharmacological and Pharmachemistrical Overview of Anti-obesity Herbs, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 2, 24-29. https://doi.org/10.5281/zenodo.14785803

More related articles
A Review Of The Dragon Fruit’s Nutritional Compo...
NIVETHITHA.K.K, VISHNUPRIYA.R, DR.RENI.A, ...
Challenges and Opportunities in Pharmacovigilance ...
Debobrata Sharma, Sidratul Montaha, Md. Fahim Bin Bashar, Md. Sai...
In Vitro Comparative Evaluation of Paracetamol and...
Anil Parasnath Sao , Suman Kumar Sinha , Roushan Kumar Singh , ...
Pharmacognostic Studies, Phytochemical Screening And Physicochemical Analysis Of...
Munish choudhary , Dev Prakash Dahiya, Chinu Kumari , Bhopesh Kumar, Anita, Dinesh Kumar Thakur, ...
UPLC-MS Method Development and Validation for Fluticasone Propionate: A Comprehe...
Vishweshwari Bhagat, Monali Khatake, Mansi Shelke, Tanvi Kambale, Nikita Pabale, Dnyaneshwari Kurhe...
Related Articles
Emerging Monoclonal Antibodies for Treatment of Various Diseases: Recent Advance...
Anita Rathod, Neha Khadse, Anjali Rathod, Ashok Chopane, Sapna Ghuge, Kavita Gaikwad, Manisha Khanda...
Sandalwood: A phytochemical and pharmacological Overview...
Shivani Wadichar, Pratik Dhokane, Swapnil Tirmanwar, Gopal Pondhe, Saurabh Kolaskar , Swejal Tarahan...
Optimizing Herbal Lozenges: Formulation Techniques and Efficacy Evaluation...
V. Anitha, L. Gopi, R. Aishwarya, L. Akash, A. Afroze, A. Abdullah, ...
More related articles
Challenges and Opportunities in Pharmacovigilance Implementation in Bangladesh: ...
Debobrata Sharma, Sidratul Montaha, Md. Fahim Bin Bashar, Md. Saidur Rahman, ...
In Vitro Comparative Evaluation of Paracetamol and Metformin Branded and Generic...
Anil Parasnath Sao , Suman Kumar Sinha , Roushan Kumar Singh , ...
Challenges and Opportunities in Pharmacovigilance Implementation in Bangladesh: ...
Debobrata Sharma, Sidratul Montaha, Md. Fahim Bin Bashar, Md. Saidur Rahman, ...
In Vitro Comparative Evaluation of Paracetamol and Metformin Branded and Generic...
Anil Parasnath Sao , Suman Kumar Sinha , Roushan Kumar Singh , ...